2021
DOI: 10.1080/15592294.2021.1959742
|View full text |Cite
|
Sign up to set email alerts
|

Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT/HDAC2 epigenomic landscape in the neurodegenerative brain

Abstract: Disruption of histone acetylation-mediated gene control is a critical step in Alzheimer's Disease (AD), yet chromatin analysis of antagonistic histone acetyltransferases (HATs) and histone deacetylases (HDACs) causing these alterations remains uncharacterized. We report the first Tip60 HAT versus HDAC2 chromatin (ChIP-seq) and transcriptional (RNA-seq) profiling study in Drosophila melanogaster brains that model early human AD. We find Tip60 and HDAC2 predominantly recruited to identical neuronal genes. Moreov… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 67 publications
1
0
0
Order By: Relevance
“…Moreover, we found increased HDAC3 levels, concomitantly with diminished H3 acetylation, in postmortem cortex of AD patients at Braak stages III-IV, which was associated with CDR of 0.5 and very mild dementia (Therriault et al, 2022). Consistent with this study, Drosophila larvae, modeling early human AD neurodegeneration, exhibited enhanced HDAC2 in the brain before Aβ deposition (Beaver et al, 2022). Importantly, we also observed increased HDAC2 and HDAC3 protein levels following AβO treatment in HT22 cells and in APP/PS1 transgenic mice, supporting the importance of targeting class I HDACis in ameliorating cognitive function and preventing neuronal dysfunction.…”
Section: Discussionsupporting
confidence: 89%
“…Moreover, we found increased HDAC3 levels, concomitantly with diminished H3 acetylation, in postmortem cortex of AD patients at Braak stages III-IV, which was associated with CDR of 0.5 and very mild dementia (Therriault et al, 2022). Consistent with this study, Drosophila larvae, modeling early human AD neurodegeneration, exhibited enhanced HDAC2 in the brain before Aβ deposition (Beaver et al, 2022). Importantly, we also observed increased HDAC2 and HDAC3 protein levels following AβO treatment in HT22 cells and in APP/PS1 transgenic mice, supporting the importance of targeting class I HDACis in ameliorating cognitive function and preventing neuronal dysfunction.…”
Section: Discussionsupporting
confidence: 89%